نتائج البحث - "Liver Cirrhosis"

المؤلفون: Cai, Kaida^1,2,3 (AUTHOR) caikaida@seu.edu.cn, Liu, Hanwen² (AUTHOR) 220241993@seu.edu.cn, Fu, Wenzhi² (AUTHOR) xinzhaomath@seu.edu.cn, Zhao, Xin^2,4 (AUTHOR)

المصدر: Axioms (2075-1680). Dec2024, Vol. 13 Issue 12, p831. 17p.

مصطلحات موضوعية: *CENSORING (Statistics), *BILIARY liver cirrhosis, *SURVIVAL analysis (Biometry), *PARAMETER estimation, *DATA analysis, *QUANTILE regression

Full Text Finder

4

Academic Journal

Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis.

المؤلفون: Warsop, Zakary¹ (AUTHOR) zakary.warsop18@imperial.ac.uk, Anand, Nikhil¹ (AUTHOR) nikhil.anand18@imperial.ac.uk, Al Maliki, Husam¹ (AUTHOR) husam.al-maliki21@imperial.ac.uk, De Souza, Shuell¹ (AUTHOR) shuell.de-souza18@imperial.ac.uk, Kamyab, Arya¹ (AUTHOR) arya.kamyab21@imperial.ac.uk, Al Hadad, Amin² (AUTHOR) m.alhadad@healthpoint.ae, Alrubaiy, Laith^2,3 (AUTHOR) l.alrubaiy@swansea.ac.uk

المصدر: Journal of Personalized Medicine. Dec2024, Vol. 14 Issue 12, p1133. 15p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *URSODEOXYCHOLIC acid, *ANTILIPEMIC agents, *BIOMARKERS, *LIVER transplantation

Full Text Finder

5

Academic Journal

Percutaneous Transhepatic Cholangioscopy in Hepatolithiasis Associated With Decompensated Cirrhosis: A Retrospective Cohort Study.

المؤلفون: Yan, Qianyu¹ (AUTHOR), Zhang, Jie¹ (AUTHOR), Chen, Rui¹ (AUTHOR), Zhang, Jingyi² (AUTHOR) jingyi223@163.com, Zhou, Rongxing¹ (AUTHOR) rongxingzhou@126.com

المصدر: Journal of Evidence-Based Medicine. Dec2024, Vol. 17 Issue 4, p843-850. 8p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *LIVER transplantation, *LIVER failure, *LIVER diseases, *CIRRHOSIS of the liver

6

Report

Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions (EMPOwer)

المؤلفون: Canadian Institutes of Health Research (CIHR)

المصدر: Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions (EMPOwer) Randomized Controlled Trial

View record in ClinicalTrials.gov

7

Academic Journal

Pain in chronic liver disease compared to other chronic conditions: Results from a contemporary nationally representative cohort study.

المؤلفون: Zhang, Grace, Cortella, Aly, Lai, Jennifer, Rubin, Jessica

المصدر: Hepatology Communications. 9(1)

مصطلحات موضوعية: Humans, Male, Female, Middle Aged, Cross-Sectional Studies, Adult, Liver Diseases, Aged, Analgesics, Opioid, United States, Liver Cirrhosis, Chronic Disease, Cohort Studies, Liver Neoplasms, Diabetes Mellitus, Logistic Models, Arthritis, Health Surveys, Chronic Pain, Hepatitis, Viral, Human, Renal Insufficiency, Chronic, Severity of Illness Index

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/35m2s8q5
https://escholarship.org/content/qt35m2s8q5/qt35m2s8q5.pdf

View record in eScholarship

8

Report

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (LCN RESCU)

المؤلفون: The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California

المصدر: Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): a Double-Blind Randomized, Placebo-Controlled Phase 2 Study

View record in ClinicalTrials.gov

9

Report

LEOPARD Prospective Validation Cohort 1 (LEOPARD PVC1)

المؤلفون: University Luxembourg (UNILU) - ELIXIR, Hospital Universitario La Fe, ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (ECRIN), Ophiomics - Precision Medicine, EF CLIF, INSERM 1149, INSERM U1052

المصدر: Validation of LEOPARD Predictive Models of Delisting in Liver Transplant Candidates: the LEOPARD Longitudinal Multicentre Prospective Validation Cohort 1, with Bio- and Tissue Collection

View record in ClinicalTrials.gov

10

Academic Journal

Associations between sleep disorders and clinical outcomes of patients with primary biliary cholangitis.

المؤلفون: Dong, Shijing¹ (AUTHOR), Zhou, Simin¹ (AUTHOR), Liu, Jiangpeng¹ (AUTHOR), Chen, Nian¹ (AUTHOR), Li, Jiwen¹ (AUTHOR), Han, Zongze¹ (AUTHOR), Liu, Ruiyun¹ (AUTHOR), Xuan, Chenyang¹ (AUTHOR), Wang, Weirong¹ (AUTHOR), Guo, Liping¹ (AUTHOR) glp0626@163.com, Zhou, Lu¹ (AUTHOR) lzhou01@tmu.edu.cn

المصدر: Advances in Medical Sciences (Elsevier Inc.). Sep2024, Vol. 69 Issue 2, p385-390. 6p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *SLEEP quality, *SLEEP interruptions, *SLEEP, *IMMUNOGLOBULIN M, *CHOLANGITIS

11

Academic Journal

A varying coefficient model with matrix valued covariates.

المؤلفون: Zhang, Hong-Fan¹ (AUTHOR) zhfbeyond@126.com

المصدر: Journal of Nonparametric Statistics. Sep2024, Vol. 36 Issue 3, p673-705. 33p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *PRINCIPAL components analysis, *ASYMPTOTIC distribution, *TIME measurements, *MATRICES (Mathematics)

12

Academic Journal

Gallbladder mucoceles in dogs: a novel form of acquired CFTR dysfunction causing localized cystic fibrosis-like disease.

المؤلفون: Meyerholz, David K.¹ (AUTHOR) david-meyerholz@uiowa.edu, Stoltz, David A.² (AUTHOR) david-stoltz@uiowa.edu

المصدر: American Journal of Physiology: Gastrointestinal & Liver Physiology. Dec2024, Vol. 327 Issue 6, pG847-G849. 3p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *CYSTIC fibrosis transmembrane conductance regulator, *CHOLECYSTECTOMY, *ION transport (Biology), *TOBACCO smoke

13

Academic Journal

Biliary cirrhosis associated with WDR19-related ciliopathy in siblings.

المؤلفون: Ravanbakhsh, Naseem^1,2 (AUTHOR) Nravanbakhsh@luriechildrens.org, Genyk, Yuri^2,3 (AUTHOR), Cheng, Alauna⁴ (AUTHOR), Vats, Divya⁵ (AUTHOR), Yanni, George² (AUTHOR)

المصدر: Journal of Hepatology. Dec2024, Vol. 81 Issue 6, pe264-e266. 3p.

مصطلحات موضوعية: *BILIARY liver cirrhosis, *CILIOPATHY, *SIBLINGS

14

Report

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) (ELONSEN)

المصدر: A Phase III, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Elafibranor 80 mg in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

Other URLs: https://vivli.org/members/ourmembers/

View record in ClinicalTrials.gov

15

Report

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment (ELFINITY)

المصدر: Prospective Non-interventional, Phase IV Multicentre Study to Assess the Effectiveness, Safety and Tolerability of Elafibranor 80 mg/Day in Participants With Primary Biliary Cholangitis Receiving Treatment in a Real-world Setting.

Other URLs: https://vivli.org/members/ourmembers/

View record in ClinicalTrials.gov

16

Report

A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

المصدر: Safety, Tolerability and Pharmacodynamics of BI 770371 Administered Intravenously in Patients With Compensated Cirrhosis Due to MASH: a Phase IIa, Multi-center, Randomized, Double-blind, Placebo-controlled Trial

Other URLs: https://www.mystudywindow.com/msw/datasharing

View record in ClinicalTrials.gov

17

Report

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

المصدر: A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

View record in ClinicalTrials.gov

18

Report

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) (IDEAL)

المصدر: IDEAL: A 52-week, Double-blind, Placebo-controlled, Randomized, Phase 3 Study Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

View record in ClinicalTrials.gov

19

Report

Endothelin Receptor Antagonism with Ambrisentan to Treat Hepatorenal Syndrome

المصدر: A Multi-Centre, Randomised, Open-Label, Phase II Study of Ambrisentan in Patients with Hepatorenal Syndrome
Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G; International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015 Apr;64(4):531-7. doi: 10.1136/gutjnl-2014-308874. Epub 2015 Jan 28. No abstract available.
Soper CP, Latif AB, Bending MR. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet. 1996 Jun 29;347(9018):1842-3. No abstract available.
Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013;38(4):345-54. doi: 10.1159/000355540. Epub 2013 Oct 5.
Ring-Larsen H. Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function. Scand J Clin Lab Invest. 1977 Nov;37(7):635-42. doi: 10.3109/00365517709100657.
Moore K. Endothelin and vascular function in liver disease. Gut. 2004 Feb;53(2):159-61. doi: 10.1136/gut.2003.024703.
Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992 Dec 17;327(25):1774-8. doi: 10.1056/NEJM199212173272502.
Zipprich A, Gittinger F, Winkler M, Dollinger MM, Ripoll C. Effect of ET-A blockade on portal pressure and hepatic arterial perfusion in patients with cirrhosis: A proof of concept study. Liver Int. 2021 Mar;41(3):554-561. doi: 10.1111/liv.14757. Epub 2021 Jan 5.
Dhaun N, Macintyre IM, Melville V, Lilitkarntakul P, Johnston NR, Goddard J, Webb DJ. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension. 2009 Jul;54(1):113-9. doi: 10.1161/HYPERTENSIONAHA.109.132670. Epub 2009 Jun 8.
Wong F, Moore K, Dingemanse J, Jalan R. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Hepatology. 2008 Jan;47(1):160-8. doi: 10.1002/hep.21940.

View record in ClinicalTrials.gov

20

Report

Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy (GOODHEART-ACLF)

المساهمون: Madhumita Premkumar, Associate Professor

المصدر: Thromboelastometry Guided Transfusion Protocol Versus Standard Care in Acute-on-Chronic Liver Failure with Bleeding: a Prospective Intervention Trial

View record in ClinicalTrials.gov

تنقيح النتائج